Orient EuroPharma Co., Ltd. (TPEX:4120)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
49.25
+0.25 (0.51%)
Apr 2, 2025, 1:30 PM CST
13.35%
Market Cap 4.25B
Revenue (ttm) 4.39B
Net Income (ttm) -283.93M
Shares Out 86.75M
EPS (ttm) -3.27
PE Ratio n/a
Forward PE n/a
Dividend 1.00 (2.07%)
Ex-Dividend Date n/a
Volume 7,162
Average Volume 73,116
Open 49.35
Previous Close 49.00
Day's Range 48.75 - 49.35
52-Week Range 40.30 - 60.70
Beta 0.43
RSI 39.09
Earnings Date Feb 27, 2025

About Orient EuroPharma

Orient EuroPharma Co., Ltd., a pharmaceutical company, develops and manufactures drugs worldwide. Its prescription medicines include cardiovascular, metabolism, neurology, obstetrics and gynecology, respiratory, andrology, immunology, antibiotic, and anti-cancer drugs. The company also provides nutrition and baby care products, such as milk and nutritional supplements under the Karihome, Babecare, and Ostricare brands; and healthcare supplements, such as thermal water for the treatment of oral and periodontal diseases under the Buccotherm name.... [Read more]

Sector Healthcare
Founded 1982
Employees 339
Stock Exchange Taipei Exchange
Ticker Symbol 4120
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.